Literature DB >> 1373389

Alveolar accumulation of fibronectin and hyaluronan precedes bleomycin-induced pulmonary fibrosis in the rat.

J Hernnäs1, O Nettelbladt, L Bjermer, B Särnstrand, A Malmström, R Hällgren.   

Abstract

The development of bleomycin-induced pulmonary fibrosis in rats was studied over a period of 30 days after an intratracheal instillation of bleomycin. Fibronectin was visualized in histological sections and quantified in bronchoalveolar lavage fluid (BALF) and related to simultaneous measurements of hyaluronan, collagen and albumin in BALF and/or lung tissue extracts. An increase in BALF fibronectin levels was noted after 3 days and the peak value a sixty fold increase was noted at day 7. Thereafter, the fibronectin levels declined and reached control values on day 21. A pronounced, patchily distributed staining for fibronectin appeared in the injured alveolar tissue parallel to the increased lavage fluid fibronectin levels on days 3-7. A fainter, streakily distributed fibronectin staining remained within the alveolar walls in areas with proliferating fibroblasts on days 14-30. Albumin in BALF increased to a peak level, 20 times control values, after 3 days and then rapidly declined. Thus, the ratio of fibronectin to albumin increased to a peak value of 43 times control values on day 7, indicating that plasma leakage cannot be the only source of the observed increase in lavage fibronectin. Lung tissue hydroxyproline increased between days 7 and 30, whereas extractable hyaluronan in lung tissue and bronchoalveolar lavage fluid peaked on days 3-7 and then gradually declined towards normal values on days 21-30. These data demonstrate that fibronectin accumulates in the alveolar tissue during the early inflammatory phase of the bleomycin-induced lung injury, parallelling hyaluronan accumulation and preceding the development of pulmonary fibrosis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1373389

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  29 in total

1.  Extracellular matrix influences alveolar epithelial claudin expression and barrier function.

Authors:  Michael Koval; Christina Ward; Mary K Findley; Susanne Roser-Page; My N Helms; Jesse Roman
Journal:  Am J Respir Cell Mol Biol       Date:  2009-05-07       Impact factor: 6.914

Review 2.  Emerging Therapies for Spastic Movement Disorders.

Authors:  Preeti Raghavan
Journal:  Phys Med Rehabil Clin N Am       Date:  2018-06-02       Impact factor: 1.784

3.  Inhibiting Fibronectin Attenuates Fibrosis and Improves Cardiac Function in a Model of Heart Failure.

Authors:  Iñigo Valiente-Alandi; Sarah J Potter; Ane M Salvador; Allison E Schafer; Tobias Schips; Francisco Carrillo-Salinas; Aaron M Gibson; Michelle L Nieman; Charles Perkins; Michelle A Sargent; Jiuzhou Huo; John N Lorenz; Tony DeFalco; Jeffery D Molkentin; Pilar Alcaide; Burns C Blaxall
Journal:  Circulation       Date:  2018-09-18       Impact factor: 29.690

4.  Long non-coding RNA MEG3 impacts diabetic nephropathy progression through sponging miR-145.

Authors:  Junfeng Li; Xia Jiang; Lijun Duan; Wei Wang
Journal:  Am J Transl Res       Date:  2019-10-15       Impact factor: 4.060

5.  Control of fibroblast fibronectin expression and alternative splicing via the PI3K/Akt/mTOR pathway.

Authors:  Eric S White; Rommel L Sagana; Adam J Booth; Mei Yan; Ashley M Cornett; Christopher A Bloomheart; Jessica L Tsui; Carol A Wilke; Bethany B Moore; Jeffrey D Ritzenthaler; Jesse Roman; Andrés F Muro
Journal:  Exp Cell Res       Date:  2010-07-13       Impact factor: 3.905

6.  Altered expression of small proteoglycans, collagen, and transforming growth factor-beta 1 in developing bleomycin-induced pulmonary fibrosis in rats.

Authors:  G Westergren-Thorsson; J Hernnäs; B Särnstrand; A Oldberg; D Heinegård; A Malmström
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

Review 7.  TGF-β1 Signaling and Tissue Fibrosis.

Authors:  Kevin K Kim; Dean Sheppard; Harold A Chapman
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-04-02       Impact factor: 10.005

8.  Extracellular superoxide dismutase inhibits inflammation by preventing oxidative fragmentation of hyaluronan.

Authors:  Fei Gao; Jeffrey R Koenitzer; Jacob M Tobolewski; Dianhua Jiang; Jiurong Liang; Paul W Noble; Tim D Oury
Journal:  J Biol Chem       Date:  2007-12-28       Impact factor: 5.157

9.  An essential role for fibronectin extra type III domain A in pulmonary fibrosis.

Authors:  Andrés F Muro; Federico A Moretti; Bethany B Moore; Mei Yan; Rachelle G Atrasz; Carol A Wilke; Kevin R Flaherty; Fernando J Martinez; Jessica L Tsui; Dean Sheppard; Francisco E Baralle; Galen B Toews; Eric S White
Journal:  Am J Respir Crit Care Med       Date:  2007-12-20       Impact factor: 21.405

10.  Short course dexamethasone treatment following injury inhibits bleomycin induced fibrosis in rats.

Authors:  W A Dik; R J McAnulty; M A Versnel; B A E Naber; L J I Zimmermann; G J Laurent; S E Mutsaers
Journal:  Thorax       Date:  2003-09       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.